Paper42947762PubMed
Combined fecal microbiota transplantation and adipose-derived stem cells protect the blood-spinal cord barrier after spinal cord injury.
Tang Z and 9 others. Front Immunol, 2026.
Cite this record
ConductScience Library. Combined fecal microbiota transplantation and adipose-derived stem cells protect the blood-spinal cord barrier after spinal cord injury. Papers, record 42947762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42947762
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combined fecal microbiota transplantation and adipose-derived stem cells protect the blood-spinal cord barrier after spinal cord injury.
- Journal
- Front Immunol
- Year
- 2026
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't
- Revised in PubMed
- 2026-10-30
Source PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Spinal Cord Injuries | Major topic |
| Blood-Spinal Cord Barrier | Major topic |
| Fecal Microbiota Transplantation | Major topic |
| Stem Cell Transplantation | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Mice, Inbred C57BL | |
| Disease Models, Animal | |
| Recovery of Function | |
| Female | |
| Combined Modality Therapy |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33292072 | Blood-Spinal Cord Barrier in Spinal Cord Injury: A Review. | J Neurotrauma | 2021 | https://conductscience.org/library/papers/33292072 | PubMed |
| 2 | 37287066 | Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies. | Stem Cell Res Ther | 2023 | https://conductscience.org/library/papers/37287066 | PubMed |
| 3 | 33678185 | Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis. | Microbiome | 2021 | https://conductscience.org/library/papers/33678185 | PubMed |
| 4 | 39354635 | Progression of mesenchymal stem cell regulation on imbalanced microenvironment after spinal cord injury. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/39354635 | PubMed |
| 5 | 41660243 | Gut-lung axis perturbation and Bifidobacterium potential after spinal cord injury in humans and mice. | iScience | 2026 | https://conductscience.org/library/papers/41660243 | PubMed |
| 6 | 29497350 | Interleukin-10 attenuates impairment of the blood-brain barrier in a severe acute pancreatitis rat model. | J Inflamm (Lond) | 2018 | https://conductscience.org/library/papers/29497350 | PubMed |
| 7 | 36716673 | SIRT1 attenuates blood-spinal cord barrier disruption after spinal cord injury by deacetylating p66Shc. | Redox Biol | 2023 | https://conductscience.org/library/papers/36716673 | PubMed |
| 8 | 31039819 | Sustained interleukin-10 delivery reduces inflammation and improves motor function after spinal cord injury. | J Neuroinflammation | 2019 | https://conductscience.org/library/papers/31039819 | PubMed |
| 9 | 35831906 | TSG-6 released from adipose stem cells-derived small extracellular vesicle protects against spinal cord ischemia reperfusion injury by inhibiting endoplasmic reticulum stress. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35831906 | PubMed |
| 10 | 34179015 | HGF and MET: From Brain Development to Neurological Disorders. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34179015 | PubMed |
| 11 | 30216653 | Mesenchymal stromal cell potency to treat acute kidney injury increased by ultrasound-activated interferon-γ/interleukin-10 axis. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/30216653 | PubMed |
| 12 | 40405285 | Autophagy modulation by hADSCs and green light therapy alleviates inflammation and promotes functional recovery after spinal cord injury. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40405285 | PubMed |
| 13 | 36882782 | Role of interleukin-6 and interleukin-10 in morphological and functional changes of the blood-brain barrier in hypertriglyceridemia. | Fluids Barriers CNS | 2023 | https://conductscience.org/library/papers/36882782 | PubMed |
| 14 | 24237182 | Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. | J Neurotrauma | 2014 | https://conductscience.org/library/papers/24237182 | PubMed |
| 15 | 39161365 | Adipose-derived stem cell therapy for spinal cord injuries: Advances, challenges, and future directions. | Regen Ther | 2024 | https://conductscience.org/library/papers/39161365 | PubMed |
| 16 | 33875384 | Butyrate modulates adipose-derived stem cells isolated from polygenic obese and diabetic mice to drive enhanced immunosuppression. | Cytotherapy | 2021 | https://conductscience.org/library/papers/33875384 | PubMed |
| 17 | 33029008 | Microglia-organized scar-free spinal cord repair in neonatal mice. | Nature | 2020 | https://conductscience.org/library/papers/33029008 | PubMed |
| 18 | 38395929 | Apoptotic extracellular vesicles derived from hypoxia-preconditioned mesenchymal stem cells within a modified gelatine hydrogel promote osteochondral regeneration by enhancing stem cell activity and regulating immunity. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38395929 | PubMed |
| 19 | 38092763 | Spinal cord injury-induced gut dysbiosis influences neurological recovery partly through short-chain fatty acids. | NPJ Biofilms Microbiomes | 2023 | https://conductscience.org/library/papers/38092763 | PubMed |
| 20 | 17549731 | Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. | J Neurosci Res | 2007 | https://conductscience.org/library/papers/17549731 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| BioProject | PRJNA1518846 |
Source BioProject
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42947762
GET https://conductscience.org/api/papers/v1/42947762/references?page=2